The controversial Swiss pharmaceutical company Novartis has started work to expand health-care access in low-income countries through its nonprofit Novartis Foundation. The expansion into a role that builds health systems is stirring all kinds of questions.
So has India won the patent war with Big Pharma? Not really. As I wrote when the Novartis ruling came down, India won a battle but the war likely continues.
The Indian Supreme Court has rejected a drug patent application by the international pharmaceutical firm Novartis, an event that merited coverage by the New York Times, BBC and many other media – news which you might think is mostly a matter for the business page or drug industry insiders. In fact, the case may represent one of the most difficult dilemmas in global health. It is a fight that is far from over.
Flickr, Brooks Elliott One of the biggest, thorniest dilemmas in global health is coming to a head in India. (And…